How Does TAVR Compare with SAVR After 5 Years?

Dr. Michael Reardon and Dr. Neal Kleiman, a CV surgeon and interventional cardiologist at Houston Methodist, assume a prominent role in the conversation at TCT 2021, as their team reveals 5-year SURTAVI trial results, shedding new light on TAVR’s longer term benefits.

Learn More in Leading Medicine

Resolved Common presentation

Why you should join Figure 1

• Share your knowledge with our global community of healthcare professionals
• Get help from experts in your field
• Learn from our library of real-world cases and quizzes

Similar cases

Doppler echocardiography in aortic stenosis.

large retroperitoneal hematoma S/P TAVR

Dr. Michael Reardon, chair of cardiovascular research at Houston Methodist, assumes a prominent role in the conversation, presenting a talk on patients who may fare better with surgery than TAVR. As the age of patients wanting TAVR continues to drop, the need for more than one procedure comes into question.